Month: May 2012

  • By Sherri Oslick — In an effort to catch up with recently filed biotech and pharma cases, Patent Docs presents this additional installment of Court Report.  Janssen Products, L.P. et al. v. Lupin Ltd. et al.2:12-cv-02840; filed May 10, 2012 in the District Court of New Jersey • Plaintiffs:  Janssen Products, L.P.; Janssen R&D Ireland;…

  • By Donald Zuhn — As part of its efforts to implement the Leahy-Smith America Invents Act, the U.S. Patent and Trademark Office issued a Federal Register notice (77 Fed. Reg. 3748) earlier this year indicating that the Office had begun to collect information on independent second opinion genetic diagnostic testing where patents and exclusive licenses…

  • By Donald Zuhn — Last week, the U.S. Patent and Trademark Office published a notice if the Federal Register (77 Fed. Reg. 28331) proposing another increase in patent fees.  The newly proposed adjustment in fees, which would go into effect on October 1, 2012, is intended to reflect fluctuations in the Consumer Price Index (CPI). …

  • By Sherri Oslick — About Court Report:  Each week we will report briefly on recently filed biotech and pharma cases. Orion Corp. v. Mylan Pharmaceuticals Inc.1:12-cv-00523; filed April 26, 2012 in the District Court of Delaware Infringement of U.S. Patent Nos. 5,446,194 ("Pharmacologically active catechol derivatives," issued August 29, 1995), 6,500,867 ("Pharmaceutical Composition Comprising Entacapone,…

  • By James DeGiulio — Last week, the U.S. Food and Drug Administration held a public hearing on the Draft Guidance on Biosimilar Development, where researchers, payors, patient and physician groups, and industry advocates provided their thoughts on the FDA's first attempt to clarify the logistics as to the operation of the Biologics Price Competition and…

  • May 21, 2012 – Patent Institutions Summit (Stanford Program in Law, Science & Technology and the Berkeley Center for Law & Technology) – Stanford Law School May 22-23, 2012 – Biosimilars*** (American Conference Institute) – New York, NY June 1, 2012 – Understanding the America Invents Act: A Sweeping Change of U.S. Patent Prosecution Practice…

  • Conference producer marcus evans will be holding its 5th Product and Pipeline Enhancement for Generics conference on July 17-19, 2012 in Washington, DC.  The conference will enable attendees to: • Assess the most recent FDA proposals regarding biosimilars development and user fees for generic companies;• Develop key strategies to balance and diversify a company's global…

  • The American Bar Association (ABA) Section of Intellectual Property Law, Young Lawyers Division, and Center for Continuing Legal Education will be offering a live webinar and teleconference entitled "Understanding the America Invents Act: A Sweeping Change of U.S. Patent Prosecution Practice" on June 1, 2012 from 1:00 – 2:30 pm (EDT).  Donna Meuth, Senior Patent…

  • By Kevin E. Noonan — In a dissent from the Federal Circuit's affirmance of a Board determination of obviousness, Judge Newman raises a jurisdictional and separation-of-powers argument in In re Baxter International, Inc. that is destined to be decided by the Supreme Court.  Specifically, what power does the U.S. Patent and Trademark Office have to…

  • By Donald Zuhn — A survey on consumer perceptions regarding food technology indicates that many U.S. consumers have favorable opinions concerning the benefits offered by plant and animal biotechnology.  The survey, which was commissioned by the International Food Information Council (IFIC), a nonprofit, nonpartisan organization established in 1985 to effectively communicate science-based information about food safety…